California · Nonprofit
MELANOMA TISSUE BANK CONSORTIUM
MELANOMA TISSUE BANK CONSORTIUM (California) receives grants from 2 organizations whose IRS filings report $2,253,476 to it, the largest being AIM AT MELANOMA ($2,253,455). 2 of them have funded it in more than one year.
- Revenue FY2025
- $321k
- Funders on record
- 2
- Grants received
- $2.3M
- Net assets
- $2.0M
What Melanoma Tissue Bank Consortium does
Mission
Melanoma Tissue Bank Consortium was created to provide tissue for fundamental public and private research.
As stated on its FY2025 Form 990.
Program
In 2025, Melanoma Tissue Bank Consortium (mtbc) received $295,000 in funding from aim at melanoma. Aim at melanoma is a not-for-profit organization that has taken the lead to pool resources in order to fund this institution. In 2025, three of the four u.s. Sites continued to collect tissue, blood, and anonymized data. Two sites transitioned research teams and paused collection for at least part of the year. The sites collected a total of 24 tissues in 2025. Also in 2025, discussions and preliminary next steps continued to take place in order to open the two sites of the tissue bank in australia and to start collecting tissue there. Mtbc anticipates granting significant funding to continue collecting tissue samples at all four us sites as well as for opening two sites in australia.
$215,723 spentof which $206,799 as grants100% of program spending
The program described on its FY2025 Form 990. Program spending in total: $215,723.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $1.4M to $1.7M (+26%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
92% of MELANOMA TISSUE BANK CONSORTIUM’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base broadened from 1 funder to 2 funders, grant income rose $202k → $500k.
1 of 2 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 0% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of MELANOMA TISSUE BANK CONSORTIUM’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
MELANOMA TISSUE BANK CONSORTIUM leans on a few funders — its largest provides 100% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund MELANOMA TISSUE BANK CONSORTIUM.
Largest funder’s share by year: 2017 100% · 2018 100% · 2019 100% · 2020 100% · 2021 100% · 2022 100% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of MELANOMA TISSUE BANK CONSORTIUM's grant income comes from California funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $21 arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
MELANOMA TISSUE BANK CONSORTIUM runs a healthier operating margin than three-quarters of the 7,883 health nonprofits its size.
this organization peer median middle 50% of peers· 7,883 health nonprofits $100k–$1M, FY2025
Organizations like MELANOMA TISSUE BANK CONSORTIUM
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
97% of spending goes to programs.
Governance
Public support
96%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for MELANOMA TISSUE BANK CONSORTIUM: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds MELANOMA TISSUE BANK CONSORTIUM?
- MELANOMA TISSUE BANK CONSORTIUM (California) receives grants from 2 organizations whose IRS filings report $2,253,476 to it, the largest being AIM AT MELANOMA ($2,253,455). 2 of them have funded it in more than one year.
- How many funders does MELANOMA TISSUE BANK CONSORTIUM have?
- IRS filings report 2 organizations giving $2,253,476 in grants to MELANOMA TISSUE BANK CONSORTIUM, 2 of which have funded it in more than one year.
- Who is the largest funder of MELANOMA TISSUE BANK CONSORTIUM?
- AIM AT MELANOMA is the largest funder on record, with $2,253,455 in grants. The full list of funders is on this page.
- How can an organization like MELANOMA TISSUE BANK CONSORTIUM find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing